BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10752675)

  • 1. The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast.
    Black MH; Diamandis EP
    Breast Cancer Res Treat; 2000 Jan; 59(1):1-14. PubMed ID: 10752675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.
    Sauter ER; Tichansky DS; Chervoneva I; Diamandis EP
    Environ Health Perspect; 2002 Mar; 110(3):241-6. PubMed ID: 11882474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possible value of positive PSA levels in malignant and nonmalignant breast diseases].
    Schuff-Werner P; Zingler C
    Onkologie; 2001 Feb; 24 Suppl 1():11-7. PubMed ID: 11441307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts.
    Zhao Y; Verselis SJ; Klar N; Sadowsky NL; Kaelin CM; Smith B; Foretova L; Li FP
    J Clin Oncol; 2001 Mar; 19(5):1462-7. PubMed ID: 11230492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping.
    Musrap N; Diamandis EP
    Clin Chem; 2016 Aug; 62(8):1066-74. PubMed ID: 27259815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer.
    Sauter ER; Klein G; Wagner-Mann C; Diamandis EP
    Cancer Detect Prev; 2004; 28(1):27-31. PubMed ID: 15041074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum total and free prostate-specific antigen for breast cancer diagnosis in women.
    Black MH; Giai M; Ponzone R; Sismondi P; Yu H; Diamandis EP
    Clin Cancer Res; 2000 Feb; 6(2):467-73. PubMed ID: 10690525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.
    Sauter ER; Lininger J; Magklara A; Hewett JE; Diamandis EP
    Int J Cancer; 2004 Feb; 108(4):588-91. PubMed ID: 14696124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?
    Mannello F; Gazzanelli G
    Breast Cancer Res; 2001; 3(4):238-43. PubMed ID: 11434875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen (PSA) in women.
    Yu H; Berkel H
    J La State Med Soc; 1999 Apr; 151(4):209-13. PubMed ID: 10234897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen production in the female breast: association with progesterone.
    Sauter ER; Babb J; Daly M; Engstrom PF; Ehya H; Malick J; Diamandis E
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):315-20. PubMed ID: 9568787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lady with raised prostate specific antigen: do we need to worry?
    Das S; Paul R; De U; Mukhopadhyay M
    Asian Pac J Cancer Prev; 2011; 12(8):2051-3. PubMed ID: 22292649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen and insulin-like growth factor binding protein-3 in nipple aspirate fluid are associated with breast cancer.
    Sauter ER; Chervoneva I; Diamandis A; Khosravi JM; Litwin S; Diamandis EP
    Cancer Detect Prev; 2002; 26(2):149-57. PubMed ID: 12102150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of prostate-specific antigen in men and women.
    Yu H
    J Gend Specif Med; 2000; 3(2):45-8, 53. PubMed ID: 11253246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings.
    Sauter ER; Wagner-Mann C; Ehya H; Klein-Szanto A
    Cancer Detect Prev; 2007; 31(1):50-8. PubMed ID: 17317033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate. A blind trial with 420 patients.
    Devine PL; McGuckin MA; Ramm LE; Ward BG; Pee D; Long S
    Cancer; 1993 Sep; 72(6):2007-15. PubMed ID: 7689923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk.
    Sauter ER; Daly M; Linahan K; Ehya H; Engstrom PF; Bonney G; Ross EA; Yu H; Diamandis E
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):967-70. PubMed ID: 8959318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen in nipple aspiration fluid: menstrual cycle variability and correlation with serum prostate-specific antigen.
    Mitchell G; Sibley PE; Wilson AP; Sauter E; A'Hern R; Eeles RA
    Tumour Biol; 2002; 23(5):287-97. PubMed ID: 12595745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate specific antigen as a biomarker for breast cancer: a meta-analysis study.
    Li HF; Xie Q; Nie QW; Ye X
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4188-4195. PubMed ID: 30024607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.